Professor of Medicine, Louisiana State University New Orleans
Cardiology
Dr. Frank W. Smart, MD
|
|
Give Review
Frank Smart practices Cardiology. He attended Baylor College of Medicine. He received awards:"America's Top Doctors", "Inside Jersey Magazine Top Doctors", "Top Doctors: New York Metro Area", "NJ.com Top Doctors", "New Jersey Life - Top Heart Doctors and OB-GYN", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Frank Smart is a published MD. He published 77 publications, including: 'A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.' He accepts Medicare.
Publications
- Photoplethysmography as a single source for analysis of sleep-disordered breathing in patients with severe cardiovascular disease.
- Long-term assessment of nocturnal Cheyne-Stokes respiration in patients with heart failure.
- Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
- Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
- Mycotic pseudo-aneurysm of the ascending thoracic aorta after cardiac transplantation.
- Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support.
- Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency?
- Prognostic value of the QTc interval after cardiac transplantation.
- Left ventricular assist device therapy for end-stage congestive heart failure: from REMATCH to the future.
- Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
- Images in cardiovascular medicine. High left ventricular assist device flows resulting from combined native aortic valve and outflow valve regurgitation.
- A successful anticoagulation protocol for the first HeartMate II implantation in the United States.
- Left ventricular free wall rupture in acute myocardial infarction: a case report and literature review.
- Posttransplant off-pump coronary bypass and laser revascularization in a Jehovah's Witness.
- Left ventricular assist device implantation in a patient with congenitally corrected transposition of the great arteries.
- Cardiomyocyte transplantation in a porcine myocardial infarction model.
- Potentiation of endothelium-dependent hyperpolarization to serotonin by dietary intake of NC 020, a defined fish oil, in the porcine coronary artery.
- Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart.
- Cardiovascular adaptation to cyclosporine-induced hypertension.
- The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure.
- Mitral inflow and pulmonary venous Doppler measurements do not predict pulmonary capillary wedge pressure in heart transplant recipients.
- Cyclosporine-induced hypertension in cardiac transplantation.
- Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine.
- An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vascu...
- Lung transplantation in Louisiana: report of the first twenty lung transplants performed in the state.
- Cardiac assist devices: bridging and beyond.
- Current issues in advanced heart failure.
- Induction immunosuppression with the monoclonal antibody OKT3 after cardiac transplantation.
- High-risk surgery as an alternative to transplantation.
- Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.
- Detection of transplant arteriopathy: does exercise thallium scintigraphy improve noninvasive diagnostic capabilities?
- Cardiac allograft vasculopathy: current concepts.
- Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
- Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation.
- Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis.
- Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
- Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men.
- Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
- Valvular regurgitation and right-sided cardiac pressures in heart transplant recipients by complete Doppler and color flow evaluation.
- Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation.
- Effects of intracoronary acetylcholine infusion early versus late after heart transplant.
- Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure.
- Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
- Lipid-lowering therapy and long-term survival in heart transplantation.
- Heterotopic heart transplantation and native heart ventricular arrhythmias.
- Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
- New developments in the diagnosis and management of cardiac allograft vasculopathy.
- The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation.
- Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy.
- Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
- Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
- Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.
- Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
- A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
- A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension wi...
- Management of cardiac allograft vasculopathy by transmyocardial laser revascularization.
- Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
- Attenuation of waiting time mortality with heterotopic heart transplantation.
- The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
- Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation.
- Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant.
- Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
- Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.
- Detection of asymptomatic myocardial ischemia in a heart transplant patient before sudden death.
- Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy.
- The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
- Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy.
- Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study.
- Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support.
- Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device.
- Aorta-to-left-atrial shunting through a previously performed heterotopic heart transplant: an unusual complication of orthotopic re-transplantation.
- Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change.
- Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
- Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.
- Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
- The value of cardiac magnetic resonance imaging in the diagnosis of isolated non-compaction of the left ventricle.
Schools
Louisiana State Univ School Of Medicine In New Orleans
Ochsner Clinic Foundation
Southeastern Louisiana University
Procedures Preformed
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Inside Jersey Magazine Top Doctors
- Top Doctors: New York Metro Area
- NJ.com Top Doctors
- New Jersey Life - Top Heart Doctors and OB-GYN
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Baylor College of Medicine -
Ochsner Clinic Foundation -
Louisiana State University School of Medicine in New Orleans
Drug Facts
| NPI NUMBER | 1275571341 | |
| NPPES Provider LastName | SMART | |
| NPPES Provider FirstName | FRANK | |
| NPPES Provider ZIPCode | 701154637 | |
| NPPES Provider State | LA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1847.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275571341 |
| Last Name Of The Provider | SMART |
| First Name Of The Provider | FRANK |
| View All |
Similar Doctors
|
Dr. Sanjay Dravid, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Muhammad Khalid, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Samuel J. Ferris, MD
This Doctor is OpenDoctor Recommended.
|